✦ LIBER ✦
A phase 1/2A Trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease
✍ Scribed by Robert Burakoff; Charles F. Barish; Dennis Riff; Ronald Pruitt; William Y. Chey; Francis A. Farraye; Ira Shafran; Seymour Katz; Charles L. Krone; Martha Vander Vliet; Christopher Stevens; Matthew L. Sherman; Eric Jacobson; Ronald Bleday
- Book ID
- 110087076
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 258 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.